Wordt geladen...
Memantine for late-life depression and apathy after a disabling medical event: a 12-week, double-blind placebo-controlled pilot study
OBJECTIVE: Preclinical data suggests that memantine, a noncompetitive glutamate N-methyl-D-aspartate (NMDA)-receptor blocker used for the treatment of moderate to severe Alzheimer’s disease, could reduce depressive and amotivated behavior occurring in the context of psychosocial stress. Therefore we...
Bewaard in:
| Hoofdauteurs: | , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3601891/ https://ncbi.nlm.nih.gov/pubmed/22173933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/gps.2813 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|